Mr. Kevin D. Clark This is Me

 View all 25 references Web References

1. 1. www.sec.gov

   www.sec.gov/Archives/edgar/dat - [Cached]

   Published on: 7/3/2008   Last Visited: 7/4/2008

   Kevin D. Clark
   ...
   Kevin D. Clark, age 45, was appointed as the Company's acting Chief Executive Officer in January 2008.Mr. Clark has served as the Company's Chief Operating Officer since September 2007 and as Chief Operating Officer of ImmunoVision since 1987.He also served as President of ImmunoVision from 1987 through 1995.Mr. Clark was a founding member of the Arkansas Biotech Association and, from 1995 through 2004, served as its Executive Vice President, and in 2002, served as its President.Since 2003, Mr. Clark has served as a member of the Executive Committee of the University of Arkansas Technology Development Foundation, a non-profit foundation for the commercialization of technology developed at the University of Arkansas in Fayetteville.From 2000 to 2003, Mr. Clark was a member of the Advisory Board of Arkansas BioVentures, a state and federally funded incubator program for biotechnology.

2. 2. www.smartbrief.com

   www.smartbrief.com/news/aaaa/i - [Cached]

   Published on: 4/6/2008   Last Visited: 6/19/2008

   The Company also announced today that Kevin D. Clark, the Company's Chief Operating Officer since September 2007, has been appointed acting Chief Executive Officer of the Company effective from Mr. D'Urso's resignation until the time the Company names Mr. D'Urso's permanent successor.
   ...
   In addition to serving as acting Chief Executive Officer of the Company, Mr. Clark will continue to serve as Chief Operating Officer of the Company and as Chief Operating Officer of ImmunoVision, Inc., the Company's wholly-owned subsidiary which develops, manufactures and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers.

3. 3. www.smartbrief.com

   www.smartbrief.com/news/aaaa/i - [Cached]

   Published on: 4/6/2008   Last Visited: 6/19/2008

   IVAX Diagnostics Appoints Kevin D. Clark Chief Operating Officer
   
   Sep 20, 2007 4:00 PM CDT
   
   MIAMI-- (BUSINESS WIRE) -- IVAX Diagnostics, Inc. (AMEX:IVD) announced today that, effective September 17, 2007, Kevin D. Clark has been appointed Chief Operating Officer of IVAX Diagnostics.In addition to serving as Chief Operating Officer of IVAX Diagnostics, Mr. Clark will continue to serve as Chief Operating Officer of ImmunoVision, Inc., IVAX Diagnostics' wholly-owned subsidiary which develops, manufactures and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers.
   
   Mr. Clark, age 44, has served as Chief Operating Officer of ImmunoVision since 1987 and served as President of ImmunoVision from 1987 through 1995.Mr. Clark was a founding member of the Arkansas Biotech Association and, from 1995 through 2004, served as its Executive Vice President, and in 2002, served as its President.Since 2003, Mr. Clark has served as a member of the Executive Committee of the University of Arkansas Technology Development Foundation, a non-profit foundation for the commercialization of technology developed at the University of Arkansas in Fayetteville.From 2000 to 2003, Mr. Clark was a member of the Advisory Board of Arkansas BioVentures, a state and federally funded incubator program for biotechnology.